Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
Conditions
- Advanced Intrahepatic Cholangiocarcinoma
Interventions
- DRUG: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Sponsor
CNBG-Virogin Biotech (Shanghai) Ltd.